Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NovaBay Pharmaceuticals (NBY) Debt Ratio (2016 - 2025)

Historic Debt Ratio for NovaBay Pharmaceuticals (NBY) over the last 10 years, with Q3 2025 value amounting to 0.04.

  • NovaBay Pharmaceuticals' Debt Ratio rose 22483.29% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year increase of 22483.29%. This contributed to the annual value of 0.02 for FY2024, which is 8491.22% down from last year.
  • Per NovaBay Pharmaceuticals' latest filing, its Debt Ratio stood at 0.04 for Q3 2025, which was up 22483.29% from 0.02 recorded in Q2 2025.
  • NovaBay Pharmaceuticals' Debt Ratio's 5-year high stood at 0.18 during Q1 2024, with a 5-year trough of 0.0 in Q4 2021.
  • Moreover, its 4-year median value for Debt Ratio was 0.04 (2025), whereas its average is 0.07.
  • The largest annual percentage gain for NovaBay Pharmaceuticals' Debt Ratio in the last 5 years was 22483.29% (2025), contrasted with its biggest fall of 9531.53% (2025).
  • Over the past 4 years, NovaBay Pharmaceuticals' Debt Ratio (Quarter) stood at 0.0 in 2021, then surged by 2774.11% to 0.13 in 2023, then crashed by 84.91% to 0.02 in 2024, then surged by 125.02% to 0.04 in 2025.
  • Its Debt Ratio stands at 0.04 for Q3 2025, versus 0.02 for Q2 2025 and 0.01 for Q1 2025.